Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William T Senapedis

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Seminars in Cancer Biology|April 24, 2014
Clinical translation of nuclear export inhibitors in cancerWilliam T Senapedis, Erkan Baloglu, Yosef Landesman
Molecular Biology of the Cell|April 5, 2011
Whole genome siRNA cell-based screen links mitochondria to Akt signaling network through uncoupling of electron transport chainWilliam T Senapedis, Caleb J Kennedy, Patrick M Boyle, et al.
Journal of the American Chemical Society|October 8, 2010
A structurally tunable DNA-based extracellular matrixFaisal A Aldaye, William T Senapedis, Pamela A Silver, et al.
Molecular Cancer Therapeutics|July 13, 2021
PAK4-NAMPT Dual Inhibition Sensitizes Pancreatic Neuroendocrine Tumors to EverolimusGabriel B Mpilla, Md Hafiz Uddin, Mohammed N Al-Hallak, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Seminars in Cancer Biology|April 24, 2014
Clinical translation of nuclear export inhibitors in cancerWilliam T Senapedis, Erkan Baloglu, Yosef Landesman
Molecular Biology of the Cell|April 5, 2011
Whole genome siRNA cell-based screen links mitochondria to Akt signaling network through uncoupling of electron transport chainWilliam T Senapedis, Caleb J Kennedy, Patrick M Boyle, et al.
Journal of the American Chemical Society|October 8, 2010
A structurally tunable DNA-based extracellular matrixFaisal A Aldaye, William T Senapedis, Pamela A Silver, et al.
Molecular Cancer Therapeutics|July 13, 2021
PAK4-NAMPT Dual Inhibition Sensitizes Pancreatic Neuroendocrine Tumors to EverolimusGabriel B Mpilla, Md Hafiz Uddin, Mohammed N Al-Hallak, et al.
Pageof 1